Ramsay Générale de Santé SA (GDS.PA)
EUR 9.66
(-0.21%)
EUR 9.66
(-0.21%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.89 Billion EUR | -0.9% |
| 2022 | 6.95 Billion EUR | 2.5% |
| 2021 | 6.78 Billion EUR | 1.59% |
| 2020 | 6.68 Billion EUR | -0.49% |
| 2019 | 6.71 Billion EUR | 53.96% |
| 2018 | 4.36 Billion EUR | 74.31% |
| 2017 | 2.5 Billion EUR | 6.66% |
| 2016 | 2.34 Billion EUR | -0.34% |
| 2015 | 2.35 Billion EUR | 37.11% |
| 2014 | 1.71 Billion EUR | 7.35% |
| 2013 | 1.59 Billion EUR | -9.8% |
| 2012 | 1.77 Billion EUR | -4.49% |
| 2011 | 1.85 Billion EUR | -5.1% |
| 2010 | 1.95 Billion EUR | -2.95% |
| 2009 | 2.01 Billion EUR | -5.65% |
| 2008 | 2.13 Billion EUR | 1.88% |
| 2007 | 2.09 Billion EUR | 9.65% |
| 2006 | 1.91 Billion EUR | 31.97% |
| 2005 | 1.44 Billion EUR | 22.44% |
| 2004 | 1.18 Billion EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 6.89 Billion EUR | -0.9% |
| 2023 Q2 | 6.86 Billion EUR | 0.0% |
| 2023 Q3 | 7 Billion EUR | 2.1% |
| 2023 Q4 | 6.89 Billion EUR | -1.57% |
| 2023 Q1 | 6.86 Billion EUR | -1.39% |
| 2022 Q2 | 7 Billion EUR | 0.0% |
| 2022 Q3 | 6.95 Billion EUR | -0.65% |
| 2022 Q4 | 6.95 Billion EUR | 0.0% |
| 2022 FY | 6.95 Billion EUR | 2.5% |
| 2022 Q1 | 7 Billion EUR | 3.18% |
| 2021 FY | 6.78 Billion EUR | 1.59% |
| 2021 Q1 | 6.54 Billion EUR | -2.01% |
| 2021 Q4 | 6.78 Billion EUR | 0.0% |
| 2021 Q2 | 6.54 Billion EUR | 0.0% |
| 2021 Q3 | 6.78 Billion EUR | 3.68% |
| 2020 Q3 | 6.68 Billion EUR | -1.36% |
| 2020 Q1 | 6.77 Billion EUR | 0.89% |
| 2020 Q2 | 6.77 Billion EUR | 0.0% |
| 2020 Q4 | 6.68 Billion EUR | 0.0% |
| 2020 FY | 6.68 Billion EUR | -0.49% |
| 2019 Q2 | 6.2 Billion EUR | 0.0% |
| 2019 FY | 6.71 Billion EUR | 53.96% |
| 2019 Q1 | 6.2 Billion EUR | 42.26% |
| 2019 Q3 | 6.71 Billion EUR | 8.23% |
| 2019 Q4 | 6.71 Billion EUR | 0.0% |
| 2018 FY | 4.36 Billion EUR | 74.31% |
| 2018 Q4 | 4.36 Billion EUR | 0.0% |
| 2018 Q3 | 4.36 Billion EUR | 1.8% |
| 2018 Q2 | 4.28 Billion EUR | 0.0% |
| 2018 Q1 | 4.28 Billion EUR | 71.22% |
| 2017 Q1 | 2.37 Billion EUR | 1.06% |
| 2017 Q4 | 2.5 Billion EUR | 0.0% |
| 2017 Q3 | 2.5 Billion EUR | 5.54% |
| 2017 Q2 | 2.37 Billion EUR | 0.0% |
| 2017 FY | 2.5 Billion EUR | 6.66% |
| 2016 FY | 2.34 Billion EUR | -0.34% |
| 2016 Q4 | 2.34 Billion EUR | 0.0% |
| 2016 Q3 | 2.34 Billion EUR | 0.85% |
| 2016 Q2 | 2.32 Billion EUR | 0.0% |
| 2016 Q1 | 2.32 Billion EUR | -1.19% |
| 2015 FY | 2.35 Billion EUR | 37.11% |
| 2015 Q2 | 2.25 Billion EUR | 0.0% |
| 2015 Q3 | 2.35 Billion EUR | 4.53% |
| 2015 Q4 | 2.35 Billion EUR | 0.0% |
| 2015 Q1 | 2.25 Billion EUR | 0.0% |
| 2014 Q2 | 1.67 Billion EUR | 3.89% |
| 2014 Q1 | 1.61 Billion EUR | -0.29% |
| 2014 FY | 1.71 Billion EUR | 7.35% |
| 2013 Q2 | 1.59 Billion EUR | -9.1% |
| 2013 Q1 | 1.75 Billion EUR | -1.28% |
| 2013 FY | 1.59 Billion EUR | -9.8% |
| 2013 Q4 | 1.61 Billion EUR | -0.39% |
| 2013 Q3 | 1.62 Billion EUR | 1.61% |
| 2012 FY | 1.77 Billion EUR | -4.49% |
| 2012 Q2 | 1.77 Billion EUR | -1.84% |
| 2012 Q1 | 1.8 Billion EUR | -2.98% |
| 2012 Q4 | 1.78 Billion EUR | -1.87% |
| 2012 Q3 | 1.81 Billion EUR | 2.43% |
| 2011 Q1 | 1.93 Billion EUR | -0.65% |
| 2011 Q4 | 1.86 Billion EUR | -2.42% |
| 2011 Q3 | 1.9 Billion EUR | 2.77% |
| 2011 FY | 1.85 Billion EUR | -5.1% |
| 2011 Q2 | 1.85 Billion EUR | -4.22% |
| 2010 FY | 1.95 Billion EUR | -2.95% |
| 2010 Q4 | 1.95 Billion EUR | -2.36% |
| 2010 Q3 | 1.99 Billion EUR | 2.13% |
| 2010 Q2 | 1.95 Billion EUR | -2.28% |
| 2010 Q1 | 2 Billion EUR | 0.0% |
| 2009 Q2 | 2.01 Billion EUR | 0.0% |
| 2009 FY | 2.01 Billion EUR | -5.65% |
| 2008 FY | 2.13 Billion EUR | 1.88% |
| 2007 FY | 2.09 Billion EUR | 9.65% |
| 2006 FY | 1.91 Billion EUR | 31.97% |
| 2005 FY | 1.44 Billion EUR | 22.44% |
| 2004 FY | 1.18 Billion EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Clariane SE | 15.18 Billion EUR | 54.58% |
| LNA Santé SA | 1.5 Billion EUR | -357.504% |